The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

Vaccination against SARS-CoV-2 using mRNA-based vaccines has been highly recommended for fragile subjects, including myelofibrosis patients (MF). Available data on the immune responsiveness of MF patients to mRNA SARS-CoV-2 vaccination, and the impact of the therapy with the JAK inhibitor ruxolitini...

Full description

Bibliographic Details
Main Authors: Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, Gabiria Pastore, Adele Santoni, Martina Simoncelli, Jacopo Polvere, Sara Galimberti, Claudia Baratè, Vincenzo Sammartano, Francesca Montagnani, Monica Bocchia, Donata Medaglini
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
mRNA SARS-CoV-2 vaccination
COVID-19
myelofibrosis
third booster dose
ruxolitinib
antibody response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017863/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017863/full

Similar Items